Message-ID: <30662107.1075845192206.JavaMail.evans@thyme>
Date: Fri, 1 Jun 2001 13:32:48 -0700 (PDT)
From: brown_mary_jo@lilly.com
Subject: **PRESS RELEASE** Zyprexa 
 Approved for Treatment of Schizophrenia
 in Japan
Cc: brown_mary_jo@lilly.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Bcc: brown_mary_jo@lilly.com
X-From: BROWN_MARY_JO@LILLY.COM@ENRON <IMCEANOTES-BROWN+5FMARY+5FJO+40LILLY+2ECOM+40ENRON@ENRON.com>
X-To: alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, Lay, Kenneth </O=ENRON/OU=NA/CN=RECIPIENTS/CN=KLAY>, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu, win.bischoff@ssmb.com
X-cc: BROWN_MARY_JO@LILLY.COM
X-bcc: 
X-Folder: \Lay, Kenneth\Lay, Kenneth\Inbox
X-Origin: LAY-K
X-FileName: Lay, Kenneth.pst


The attached press release was issued this morning over Business Wire at 8:50 AM EST. 

 - Japan Zyprexa Approval PR 060101.doc 